BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3881672)

  • 21. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
    Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
    J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
    Ueda M; Deguchi M; Takemura S; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):679-84. PubMed ID: 1749118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-membrane interaction: C3a, an indicator of biocompatibility.
    Ivanovich P; Hammerschmidt DE; Chenoweth D; Klinkmann H; Vidovic D
    Life Support Syst; 1985; 3 Suppl 1():394-403. PubMed ID: 3879953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement, granulocytes, and shock lung.
    Craddock PR
    Am J Emerg Med; 1984 Jan; 2(1):78-81. PubMed ID: 6517988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.
    Arnaout MA; Wang EA; Clark SC; Sieff CA
    J Clin Invest; 1986 Aug; 78(2):597-601. PubMed ID: 3090106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients.
    Suzuki Y; Uchida J; Tsuji H; Kuzuhara K; Hara S; Nihei H; Ogura Y; Otsubo O; Mimura N
    Tohoku J Exp Med; 1987 May; 152(1):35-45. PubMed ID: 3497472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
    Rainard P; Sarradin P; Paape MJ; Poutrel B
    Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological effects of recently isolated complement derived peptides].
    Gardinali M; Tucci A; Bergamaschini L; Cicardi M
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):1-7. PubMed ID: 6982047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis.
    Thylén P; Lundahl J; Fernvik E; Hed J; Svenson SB; Jacobson SH
    Am J Nephrol; 1992; 12(6):393-400. PubMed ID: 1292337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dialysis neutropenia: the role of the cytoskeleton.
    Tabor B; Geissler B; Odell R; Schmidt B; Blumenstein M; Schindhelm K
    Kidney Int; 1998 Mar; 53(3):783-9. PubMed ID: 9507227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
    Williams JJ; Yellin SA; Slotman GJ
    Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradialytic modulation of granulocyte C5a receptors.
    Himmelfarb J; Gerard NP; Hakim RM
    J Am Soc Nephrol; 1991 Oct; 2(4):920-6. PubMed ID: 1751793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis.
    Kawabata K; Nagake Y; Shikata K; Makino H; Ota Z
    Nephron; 1996; 73(4):573-9. PubMed ID: 8856254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis-activated granulocytes at the site of interstitial inflammation.
    Jacobson SH; Thylén P; Fernvik E; Halldén G; Grönneberg R; Lundahl J
    Am J Kidney Dis; 2002 Apr; 39(4):854-61. PubMed ID: 11920354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptoms and activation of granulocytes and complement with two dialysis membranes.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the kinetics of complement activation, leucopenia and granulocyte-elastase release induced by haemodialysis.
    Knudsen F; Nielsen AH; Pedersen JO; Jersild C
    Scand J Clin Lab Invest; 1985 Dec; 45(8):759-66. PubMed ID: 3878572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of a surface membrane glycoprotein (Mo1) in man.
    Dana N; Todd RF; Pitt J; Springer TA; Arnaout MA
    J Clin Invest; 1984 Jan; 73(1):153-9. PubMed ID: 6361068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.